- Home
- Publications
- Publication Search
- Publication Details
Title
Interfering with Tumor Hypoxia for Radiotherapy Optimization
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-21
DOI
10.1186/s13046-021-02000-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
- (2021) Bin Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor Oxygenation by Myo-Inositol Trispyrophosphate Enhances Radiation Response
- (2021) Ivo Grgic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Paracrine Placental Growth Factor Signaling in Response to Ionizing Radiation Is p53-Dependent and Contributes to Radioresistance
- (2021) Tamara Kazimova et al. MOLECULAR CANCER RESEARCH
- Cellular adaptation to hypoxia through hypoxia inducible factors and beyond
- (2020) Pearl Lee et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
- (2020) Yin Wang et al. ONCOGENE
- Divergent mutational processes distinguish hypoxic and normoxic tumours
- (2020) Vinayak Bhandari et al. Nature Communications
- Emerging strategies to target cancer metabolism and improve radiation therapy outcomes
- (2020) Martin Kery et al. BRITISH JOURNAL OF RADIOLOGY
- Targeting the MAPK Pathway in KRAS-Driven Tumors
- (2020) Matthias Drosten et al. CANCER CELL
- BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases
- (2020) Michelle M. Kim et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond
- (2020) Shing Yau Tam et al. Frontiers in Oncology
- Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
- (2020) Brita Singers Sørensen et al. Frontiers in Oncology
- Chetomin, a Hsp90/HIF1α pathway inhibitor, effectively targets lung cancer stem cells and non-stem cells
- (2020) Shengping Min et al. CANCER BIOLOGY & THERAPY
- Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
- (2020) Dawei Chen et al. Journal for ImmunoTherapy of Cancer
- Arsenic trioxide as a novel anti-glioma drug: a review
- (2020) Yi Fang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- The emerging role of targeting cancer metabolism for cancer therapy
- (2020) Pegah Farhadi et al. TUMOR BIOLOGY
- HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance
- (2019) Ayako Nagao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular landmarks of tumor hypoxia across cancer types
- (2019) Vinayak Bhandari et al. NATURE GENETICS
- Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
- (2019) Ruben S. A. Goedegebuure et al. Frontiers in Immunology
- Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses
- (2019) Ivana Kurelac et al. Nature Communications
- Hypoxia induces rapid changes to histone methylation and reprograms chromatin
- (2019) Michael Batie et al. SCIENCE
- Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
- (2019) Abhishek A. Chakraborty et al. SCIENCE
- Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects
- (2019) Slavisa Tubin et al. Radiation Oncology
- Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro
- (2019) Negar Sadeghi et al. NANOTECHNOLOGY
- Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications
- (2019) Zhihong Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Long-term outcomes of hypoxia modification in bladder preservation: Update from BCON trial.
- (2019) Yee Pei Song et al. JOURNAL OF CLINICAL ONCOLOGY
- Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death
- (2019) Chang W. Song et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]
- (2019) Pierre Vera et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000
- (2019) Xinjian Mao et al. CANCER BIOLOGY & THERAPY
- Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
- (2019) Zhanhuai Wang et al. Cell Communication and Signaling
- Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
- (2019) Magdalena Jarosz-Biej et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- Assessing the interactions between radiotherapy and antitumour immunity
- (2019) Clemens Grassberger et al. Nature Reviews Clinical Oncology
- The multifaceted contribution of α-ketoglutarate to tumor progression: An opportunity to exploit?
- (2019) Houda Abla et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Integration of radiotherapy and immunotherapy for treatment of oligometastases
- (2019) Sean P Pitroda et al. LANCET ONCOLOGY
- Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
- (2019) Eric Deutsch et al. LANCET ONCOLOGY
- HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor in Clear Cell Renal Cell Carcinoma Patients
- (2019) Kevin D Courtney et al. CLINICAL CANCER RESEARCH
- Metabolism and cancer: the future is now
- (2019) Christian Frezza BRITISH JOURNAL OF CANCER
- Targeting tumour hypoxia: shifting focus from oxygen supply to demand
- (2018) James T Coates et al. BRITISH JOURNAL OF RADIOLOGY
- Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis
- (2018) Susu Han et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Microwave hyperthermia promotes caspase‑3-dependent apoptosis and induces G2/M checkpoint arrest via the ATM pathway in non‑small cell lung cancer cells
- (2018) Yan-Yan Zhao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Radiation and hypoxia-induced non-targeted effects in normoxic and hypoxic conditions in human lung cancer cells
- (2018) Slavisa Tubin et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Role of metabolism in cancer cell radioresistance and radiosensitization methods
- (2018) Le Tang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation
- (2018) Yuan-Hua Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Molecular and cellular toxicological profiling of DNA bis-intercalator, quinoxaline compounds: echinomycin as the versatile lead
- (2018) Yoon-Sun Park et al. Molecular & Cellular Toxicology
- An inhibitor of oxidative phosphorylation exploits cancer vulnerability
- (2018) Jennifer R. Molina et al. NATURE MEDICINE
- EP-2323: Effects of the proteasome inhibitor bortezomib on radiosensitivity of glioblastoma cells
- (2018) C. Forster et al. RADIOTHERAPY AND ONCOLOGY
- Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy
- (2018) Yiliang Li et al. Frontiers in Immunology
- Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects
- (2018) Cho Rong Hong et al. BIOCHEMICAL PHARMACOLOGY
- Abstract 4959: CP-506, a next generation hypoxia-activated prodrug, as promising novel anti-cancer therapeutic
- (2018) sophie thiolloy et al. CANCER RESEARCH
- Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy
- (2018) Sonja Stieb et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism
- (2018) Martin Benej et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathological effects of ionizing radiation: endothelial activation and dysfunction
- (2018) Bjorn Baselet et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
- (2018) Kaitlin Graham et al. International Journal of Nanomedicine
- Impact of myo -inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models
- (2018) Ly-Binh-An Tran et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect
- (2018) Cho Rong Hong et al. NEOPLASIA
- Cancer associated fibroblasts: is the force the path to the dark side?
- (2018) Jorge Barbazán et al. CURRENT OPINION IN CELL BIOLOGY
- Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy
- (2017) Ishna N. Mistry et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme
- (2017) John L. Gainer et al. JOURNAL OF NEUROSURGERY
- Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18 F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)
- (2017) Pierre Vera et al. JOURNAL OF NUCLEAR MEDICINE
- The prognosis outcome of oral squamous cell carcinoma using HIF-2α
- (2017) Elva Lim et al. Journal of the Chinese Medical Association
- ER stress and the unfolded protein response in neurodegeneration
- (2017) Claudio Hetz et al. Nature Reviews Neurology
- Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial
- (2017) Stefan Welz et al. RADIOTHERAPY AND ONCOLOGY
- Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
- (2017) Yanqing Huang et al. Science China-Life Sciences
- A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model
- (2017) Carla Hajj et al. Translational Oncology
- HIF-2α not HIF-1α overexpression confers poor prognosis in non–small cell lung cancer
- (2017) Zhao-Jia Gao et al. TUMOR BIOLOGY
- CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma
- (2017) Hongfang Zhang et al. Cell Death & Disease
- The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination
- (2017) Nathalie van den Tempel et al. Oncotarget
- Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
- (2017) Chao Zhang et al. Oncotarget
- The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy
- (2017) Katarzyna J. Nytko et al. Oncotarget
- Barriers to Radiation-Induced In Situ Tumor Vaccination
- (2017) Erik Wennerberg et al. Frontiers in Immunology
- Redox signaling during hypoxia in mammalian cells
- (2017) Kimberly A. Smith et al. Redox Biology
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
- (2017) et al. Cancers
- Results from a phase I, dose-escalation study of PX-478, an orally available inhibitor of HIF-1α.
- (2017) R. Tibes et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
- (2016) Marte Jonsson et al. BRITISH JOURNAL OF CANCER
- Radiotherapy combination opportunities leveraging immunity for the next oncology practice
- (2016) Fernanda G. Herrera et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest
- (2016) L. Schaaf et al. CANCER RESEARCH
- Hypoxia in tissue repair and fibrosis
- (2016) Ian A. Darby et al. CELL AND TISSUE RESEARCH
- PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives
- (2016) Vivek Asati et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- RRx-001, A novel dinitroazetidine radiosensitizer
- (2016) Bryan Oronsky et al. INVESTIGATIONAL NEW DRUGS
- Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins
- (2016) Di Wang et al. Journal of X-Ray Science and Technology
- O 2 sensing, mitochondria and ROS signaling: The fog is lifting
- (2016) Gregory B. Waypa et al. MOLECULAR ASPECTS OF MEDICINE
- Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy
- (2016) Krista C.J. Wink et al. RADIOTHERAPY AND ONCOLOGY
- Quality-of-life after radiotherapy for advanced laryngeal cancer: Results of a phase III trial of the Dutch Head and Neck Society
- (2016) Geert O. Janssens et al. RADIOTHERAPY AND ONCOLOGY
- Hypoxic control of metastasis
- (2016) E. B. Rankin et al. SCIENCE
- The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
- (2016) Thomas M. Ashton et al. Nature Communications
- Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
- (2016) Marco Fiorillo et al. Oncotarget
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
- (2015) Muhammad Zaeem Noman et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Synergistic antitumor effects of radiation and proteasome inhibitor treatment in pancreatic cancer through the induction of autophagy and the downregulation of TRAF6
- (2015) Hui-Wen Chiu et al. CANCER LETTERS
- The Nuclear Factor κB pathway: A link to the immune system in the radiation response
- (2015) Christine E. Hellweg CANCER LETTERS
- The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors
- (2015) Jiuda Zhao et al. CANCER TREATMENT REVIEWS
- TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging
- (2015) S. G. J. A. Peeters et al. CLINICAL CANCER RESEARCH
- Gene Expression Signatures as Biomarkers of Tumour Hypoxia
- (2015) B.H.L. Harris et al. CLINICAL ONCOLOGY
- Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
- (2015) M. Konopleva et al. HAEMATOLOGICA
- Regulation of Hypoxia-Inducible Factor-1a by Reactive Oxygen Species : New Developments in an Old Debate
- (2015) Shahrzad Movafagh et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
- (2015) Mitesh J. Borad et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
- (2015) Rupert Courtnay et al. MOLECULAR BIOLOGY REPORTS
- Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
- (2015) Arlene L. Oei et al. Radiation Oncology
- IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma
- (2015) Mohamed A. Hassan Metwally et al. RADIOTHERAPY AND ONCOLOGY
- The Clinical Significance of Hypoxia in Human Cancers
- (2015) Neesha Dhani et al. SEMINARS IN NUCLEAR MEDICINE
- Inhibition of Hypoxia-inducible Factor-1 Alpha Radiosensitized MG-63 Human Osteosarcoma Cells in Vitro
- (2015) Zhu Jin et al. TUMORI
- Ganetespib: research and clinical development
- (2015) Shanu Modi et al. OncoTargets and Therapy
- Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
- (2015) M. Konopleva et al. HAEMATOLOGICA
- Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction
- (2015) Esther A. Kleibeuker et al. Cancer Medicine
- Inhibition of Hypoxia-inducible Factor-1 Alpha Radiosensitized MG-63 Human Osteosarcoma Cells in Vitro
- (2015) Zhu Jin et al. TUMORI JOURNAL
- Regulation of glucose metabolism by p53: Emerging new roles for the tumor suppressor
- (2015) Esha Madan et al. Oncotarget
- Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
- (2015) Tiansuo Zhao et al. Oncotarget
- Mitochondrial autophagy: Life and breath of the cell
- (2014) Gregg L. Semenza Autophagy
- Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth
- (2014) Alexander Pietras et al. Cell Stem Cell
- Prognosis value of HIF-1α expression in patients with non-small cell lung cancer
- (2014) Qian Wang et al. GENE
- Overexpression of Hypoxia-Inducible Factor-1α Is a Predictor of Poor Prognosis in Cervical Cancer
- (2014) Miaoling Huang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Heat exposure enhances radiosensitivity by depressing DNA-PK kinase activity during double strand break repair
- (2014) Makoto Ihara et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Radiation-induced signaling pathways that promote cancer cell survival (Review)
- (2014) ASHLEY L. HEIN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?
- (2014) J. Martin Brown et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Reciprocal Regulation of Hypoxia-Inducible Factor 2α and GLI1 Expression Associated With the Radioresistance of Renal Cell Carcinoma
- (2014) Jiancheng Zhou et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma
- (2014) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia
- (2014) Carme Camps et al. Molecular Cancer
- Abstract B278: PR610: A novel hypoxia-selective tyrosine kinase inhibitor in phase I clinical trial.
- (2014) A. V. Patterson et al. MOLECULAR CANCER THERAPEUTICS
- HIF-1 Alpha Overexpression Correlates with Poor Overall Survival and Disease-Free Survival in Gastric Cancer Patients Post-Gastrectomy
- (2014) Li Chen et al. PLoS One
- The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition
- (2014) Darren M. Hutt et al. PLoS One
- BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts
- (2014) Linda Helbig et al. Radiation Oncology
- PX-12 induces apoptosis in Calu-6 cells in an oxidative stress-dependent manner
- (2014) Bo Ra You et al. TUMOR BIOLOGY
- Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
- (2013) Woondong Jeong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
- (2013) V. E. Zannella et al. CLINICAL CANCER RESEARCH
- PX-12 inhibits the growth of A549 lung cancer cells via G2/M phase arrest and ROS-dependent apoptosis
- (2013) BO RA YOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Overexpression of HIF-1α indicates a poor prognosis in tongue carcinoma and may be associated with tumour metastasis
- (2013) YANG ZHENG et al. Oncology Letters
- BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I
- (2013) Peter Ellinghaus et al. Cancer Medicine
- Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy
- (2012) Camilla Molich Hoff ACTA ONCOLOGICA
- Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma
- (2012) Laura MS Seeber et al. BMC CANCER
- PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
- (2012) Mark J McKeage et al. BMC CANCER
- TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules
- (2012) Qian Liu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
- (2012) T. W. H. Meijer et al. CLINICAL CANCER RESEARCH
- Combining angiogenesis inhibition and radiotherapy: A double-edged sword
- (2012) Esther A. Kleibeuker et al. DRUG RESISTANCE UPDATES
- Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial
- (2012) Geert O. Janssens et al. JOURNAL OF CLINICAL ONCOLOGY
- Imaging hypoxia to improve radiotherapy outcome
- (2012) Michael R. Horsman et al. Nature Reviews Clinical Oncology
- Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
- (2012) Marie Saelen et al. Radiation Oncology
- Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)
- (2012) Heon Joo Park et al. RADIATION RESEARCH
- Hypoxia Gene Expression Signatures as Prognostic and Predictive Markers in Head and Neck Radiotherapy
- (2012) Kasper Toustrup et al. SEMINARS IN RADIATION ONCOLOGY
- A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients
- (2011) Mark J McKeage et al. BMC CANCER
- Understanding the benefit of metformin use in cancer treatment
- (2011) Ryan JO Dowling et al. BMC Medicine
- Volumetric modulated arc therapy: a review of current literature and clinical use in practice
- (2011) M Teoh et al. BRITISH JOURNAL OF RADIOLOGY
- PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
- (2011) Ghassan K. Abou-Alfa et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
- (2011) K. Toustrup et al. CANCER RESEARCH
- Antiangiogenic Agent Sunitinib Transiently Increases Tumor Oxygenation and Suppresses Cycling Hypoxia
- (2011) S. Matsumoto et al. CANCER RESEARCH
- Dual Inhibition of the PI3K/mTOR Pathway Increases Tumor Radiosensitivity by Normalizing Tumor Vasculature
- (2011) E. Fokas et al. CANCER RESEARCH
- Arsenic Trioxide Treatment Decreases the Oxygen Consumption Rate of Tumor Cells and Radiosensitizes Solid Tumors
- (2011) C. Diepart et al. CANCER RESEARCH
- Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy
- (2011) Renaud Mazeron et al. CANCER TREATMENT REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- HIF-1 or HIF-2 induction is sufficient to achieve cell cycle arrest in NIH3T3 mouse fibroblasts independent from hypoxia
- (2011) Thomas Hackenbeck et al. CELL CYCLE
- Chromatin as an oxygen sensor and active player in the hypoxia response
- (2011) Andrew Melvin et al. CELLULAR SIGNALLING
- Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer
- (2011) J. D. Sun et al. CLINICAL CANCER RESEARCH
- Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1 in Advanced Solid Tumors
- (2011) S. Kummar et al. CLINICAL CANCER RESEARCH
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review
- (2011) Colin H Richards et al. Future Oncology
- Acute Versus Chronic Hypoxia: Why a Simplified Classification is Simply Not Enough
- (2011) Christine Bayer et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells
- (2011) Christina D. Befani et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
- (2011) F. Meng et al. MOLECULAR CANCER THERAPEUTICS
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition
- (2011) P. M. Krawczyk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ionizing radiation and inhibition of angiogenesis in a spontaneous mammary carcinoma and in a syngenic heterotopic allograft tumor model: a comparative study
- (2011) Oliver Riesterer et al. Radiation Oncology
- Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis
- (2011) Jens Overgaard RADIOTHERAPY AND ONCOLOGY
- Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck
- (2011) Kasper Toustrup et al. RADIOTHERAPY AND ONCOLOGY
- Identifying hypoxia in human tumors: A correlation study between18F-FMISO PET and the Eppendorf oxygen-sensitive electrode
- (2010) Lise Saksø Mortensen et al. ACTA ONCOLOGICA
- HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
- (2010) Yoshifumi Baba et al. AMERICAN JOURNAL OF PATHOLOGY
- HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression
- (2010) Jacqueline Kessler et al. BMC CANCER
- A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination
- (2010) Ramesh K. Ramanathan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase
- (2010) Yon Hui Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1α expression in oral squamous cell carcinoma cells
- (2010) Eri Sasabe et al. FREE RADICAL BIOLOGY AND MEDICINE
- Expression of hypoxia-inducible factor-1 alpha (HIF-1α) in patients with the gallbladder carcinoma
- (2010) Erdenebulgan Batmunkh et al. International Journal of Clinical Oncology
- Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: Heterogeneity is the key issue
- (2010) Peter W. Vaupel et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy
- (2010) Louis Potters et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionation Results in Reduced Tumor Cell Kill Compared to Conventional Fractionation for Tumors With Regions of Hypoxia
- (2010) David J. Carlson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
- (2010) Peter J. Hoskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
- (2010) Lester J. Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Endothelial Membrane Remodeling Is Obligate for Anti-Angiogenic Radiosensitization during Tumor Radiosurgery
- (2010) Jean-Philip Truman et al. PLoS One
- Pathogenetic mechanisms in radiation fibrosis
- (2010) John Yarnold et al. RADIOTHERAPY AND ONCOLOGY
- Heterogeneity of the Tumor Vasculature
- (2010) Janice Nagy et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- In VitroComparison of Dodecafluoropentane (DDFP), Perfluorodecalin (PFD), and Perfluoroctylbromide (PFOB) in the Facilitation of Oxygen Exchange
- (2009) Jennifer L.H. Johnson et al. ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY
- BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression
- (2009) M Yan et al. BRITISH JOURNAL OF CANCER
- A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors
- (2009) Michael B. Jameson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Control of HIF-1 Expression by eIF2 Phosphorylation-Mediated Translational Repression
- (2009) K. Zhu et al. CANCER RESEARCH
- Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling
- (2009) N. Qayum et al. CANCER RESEARCH
- Targeting Heat Shock Protein 90 Overrides the Resistance of Lung Cancer Cells by Blocking Radiation-Induced Stabilization of Hypoxia-Inducible Factor-1α
- (2009) Woo-Young Kim et al. CANCER RESEARCH
- Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
- (2009) David R. Mole et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts
- (2009) A. Baschnagel et al. MOLECULAR CANCER THERAPEUTICS
- Stereotactic body radiation therapy: a novel treatment modality
- (2009) Simon S. Lo et al. Nature Reviews Clinical Oncology
- Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic Carcinoma
- (2009) Kotaro Miyake et al. PANCREAS
- HIF2 inhibition promotes p53 pathway activity, tumor cell death, and radiation responses
- (2009) J. A. Bertout et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
- (2009) X. Xia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Proteasome Inhibitor Bortezomib Increases Radiation Sensitivity in Androgen Independent Human Prostate Cancer Cells
- (2009) Serdar Goktas et al. UROLOGY
- Tumor Recovery by Angiogenic Switch from Sprouting to Intussusceptive Angiogenesis after Treatment with PTK787/ZK222584 or Ionizing Radiation
- (2008) Ruslan Hlushchuk et al. AMERICAN JOURNAL OF PATHOLOGY
- Hypoxia-inducible factor-2: effect on radiation sensitivity and differential regulation by an mTOR inhibitor
- (2008) Rupal S. Bhatt et al. BJU INTERNATIONAL
- Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1
- (2008) D. H. Shin et al. BLOOD
- Mitochondrial complex III regulates hypoxic activation of HIF
- (2008) T Klimova et al. CELL DEATH AND DIFFERENTIATION
- Hypoxia regulates TSC1/2 mTOR signaling and tumor suppression through REDD1-mediated 14 3 3 shuttling
- (2008) M. P. DeYoung et al. GENES & DEVELOPMENT
- PX-478, an inhibitor of hypoxia-inducible factor-1α, enhances radiosensitivity of prostate carcinoma cells
- (2008) Sanjeewani T. Palayoor et al. INTERNATIONAL JOURNAL OF CANCER
- Results of the Phase III ENRICH (RT-016) Study of Efaproxiral Administered Concurrent with Whole Brain Radiation Therapy (WBRT) in Women with Brain Metastases from Breast Cancer
- (2008) J.H. Suh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Reproducibility of Intratumor Distribution of 18F-Fluoromisonidazole in Head and Neck Cancer
- (2008) Sadek A. Nehmeh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors
- (2008) Hiroshi Harada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1
- (2008) M. Y. Koh et al. MOLECULAR CANCER THERAPEUTICS
- A RNA antagonist of hypoxia-inducible factor-1 , EZN-2968, inhibits tumor cell growth
- (2008) L. M. Greenberger et al. MOLECULAR CANCER THERAPEUTICS
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
- (2008) William G. Kaelin et al. MOLECULAR CELL
- Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
- (2008) P. Vaupel ONCOLOGIST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started